Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A topical feminine hygiene product developed by researchers at the University of Alberta, consisting of a perineal wipe or towel infused with an antibacterial essential oil solution, primarily featuring tea tree oil (*Melaleuca alternifolia*). The product is designed as a preventative measure against recurrent urinary tract infections (UTIs) in women by reducing the colonization of uropathogenic bacteria in the perineal area. Tea tree oil contains bioactive compounds such as terpinen-4-ol that exhibit broad-spectrum antimicrobial activity. The WIPEAWAY clinical trial was initiated as an open-label safety study to evaluate the skin tolerability and potential for irritation of the infused towel before proceeding to efficacy trials for UTI prevention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tea tree oil infused perineal wipe.